CGFAX
Price
$84.69
Change
+$0.20 (+0.24%)
Updated
Sep 5 closing price
Net Assets
331.65B
RGAHX
Price
$84.93
Change
+$0.88 (+1.05%)
Updated
Sep 4 closing price
Net Assets
331.65B
Interact to see
Advertisement

CGFAX vs RGAHX

Header iconCGFAX vs RGAHX Comparison
Open Charts CGFAX vs RGAHXBanner chart's image
American Funds Growth Fund of Amer 529A
Price$84.69
Change+$0.20 (+0.24%)
VolumeN/A
Net Assets331.65B
American Funds Growth Fund of Amer R5E
Price$84.93
Change+$0.88 (+1.05%)
VolumeN/A
Net Assets331.65B
CGFAX vs RGAHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CGFAX vs. RGAHX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGFAX is a Buy and RGAHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CGFAX (332B) and RGAHX (332B) have equal amount of cash in the bank . RGAHX pays higher dividends than CGFAX: RGAHX (0.46) vs CGFAX (0.32). CGFAX was incepted earlier than RGAHX: CGFAX (24 years) vs RGAHX (10 years). CGFAX (0.65) is less costly to investors than RGAHX (0.44). CGFAX (25.00) and RGAHX (25.00) have comparable annual turnover. CGFAX (250) and RGAHX (250) have matching initial minimum investment requirements. CGFAX (18.35) and RGAHX (18.32) have marching annual gain over last year. CGFAX (42.66) and RGAHX (42.61) have equivalent 5 years return.
CGFAXRGAHXCGFAX / RGAHX
Total Expense Ratio0.650.44148%
Annual Report Gross Expense Ratio0.650.44148%
Fund Existence24 years10 years-
Gain YTD15.76015.645101%
Front Load4%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets332B332B100%
Annual Yield % from dividends0.320.4670%
Returns for 1 year18.3518.32100%
Returns for 3 years60.3560.20100%
Returns for 5 years42.6642.61100%
Returns for 10 years105.34N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HALO74.931.53
+2.08%
Halozyme Therapeutics
ARCB75.701.27
+1.71%
ArcBest Corp
CLNN6.030.08
+1.34%
Clene Inc.
CHARU10.82N/A
N/A
Charlton Aria Acquisition Corp
BNTC13.91-0.09
-0.64%
Benitec Biopharma